Carotid-axillary artery bypass: A ten-year experience

Criado, Frank J.; Queral, Luis A.

doi:10.1016/s0741-5214(95)70062-5

Cited by 30 publications

(14 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…6C) because of technical ease and the avoidance of potential lymphatic and nerve complications associated with subclavian artery exposure. 38 More proximal device landing into the mid or proximal arch often implies the need for left carotid artery debranching. We have found the crossover right-to-left carotid-carotid retropharyngeal bypass (Fig.…”

Section: Aortic Branchesmentioning

confidence: 99%

Technical Solutions for Common Problems in TEVAR:

Criado¹,

McKendrick²,

Criado

2009

Journal of Endovascular Therapy

Self Cite

View full text Add to dashboard Cite

Thoracic endovascular aortic repair (TEVAR) is rapidly emerging as an important treatment option for several indications, and it would not be unreasonable to predict that endograft treatment may well become the predominant form of therapy for many, if not the majority, of patients. However, several unresolved issues remain, and the need for further improvements and technological refinements will not cease any time soon. Ranking high among these issues are the challenges related to endovascular access and aortic branch management, which constitute the main focus of this review. Achieving safe and successful endovascular access for introduction and deployment of the stent-graft device is a crucially important and often challenging step during TEVAR, but arterial injury has been, and continues to be, an all-too-common occurrence to this day. A clear understanding of the relevant issues and available technical solutions can go a long way toward preventing such catastrophes. A preponderance of thoracic aortic pathologies tend to develop adjacent to or within the branched segments. It is therefore not surprising that branch management issues have risen to the top of the entire TEVAR field. Debranching and vessel relocation techniques have added a whole new dimension to the therapy because they can expand or create suitable landing zones proximally and distally, thereby broadening the applicability of endograft technologies to a much larger number of patients.

show abstract

Section: Aortic Branchesmentioning

confidence: 99%

Technical Solutions for Common Problems in TEVAR:

Criado¹,

McKendrick²,

Criado

2009

Journal of Endovascular Therapy

Self Cite

View full text Add to dashboard Cite

show abstract

“…On the other hand, Infraclavicular exposure of the axillary artery is a straightforward technique routinely performed by vascular surgeons and eliminates some of the potential risks of supraclavicular approach. A review of 10-year experience with carotid-axillary artery bypass revealed a graft patency rate of 96% over a mean follow up of 47 months [22]. …”

Section: Discussionmentioning

confidence: 99%

A Case Report of Coronary-Subclavian Steal Syndrome Treated with Carotid to Axillary Artery Bypass

Al-Jundi

Saleh

Lawrence

et al. 2009

Case Reports in Medicine

View full text Add to dashboard Cite

Coronary-subclavian steal syndrome results from atherosclerotic disease of the proximal subclavian artery causing reversal of flow in an internal mammary artery used as conduit for coronary artery bypass. This rare complication of cardiac revascularisation leads to recurrence of myocardial ischaemia. When feasible, subclavian angioplasty and/or stent placement can provide acceptable result for these patients. Vascular reconstruction through carotid to subclavian artery bypass has been the standard procedure of choice. Other interventions in literature include axilloaxillary bypass and subclavian carotid transposition. This case report describes the use of carotid axillary artery bypass for the treatment of coronary-subclavian steal syndrome.

show abstract

“…We decided to perform a carotid-axillary bypass 5 and not the traditional carotid subclavian bypass due to the habitus of the patient and to avoid complications with the lymphatic channels and nerves more commonly exposed to lesions after a supraclavicular exposure. Final angio-CT, performed 1 month later, documented the good position of all the endografts and no residual infolding (Figure 3 B–D).…”

Section: Methodsmentioning

confidence: 99%

Case Report of an Endovascular Repair of a Residual Type A Dissection Using a Not CE Not FDA-Approved Najuta Thoracic Stent Graft System

et al. 2015

View full text Add to dashboard Cite

This report describes an endovascular repair of a residual type A dissection using a medical device that is not marked by european conformity (CE) or Food and Drug Administration (FDA).The patient underwent ascending aortic surgery for acute type A dissection. The 2-year angio–computed tomography demonstrated patency of the residual false lumen with evolution into a 6 cm aneurysm, the extension of the dissection from the aortic arch to the aortic bifurcation with thrombosis of the right common iliac artery. There was no CE- or FDA-marked medical device indicated for this case or any other acceptable therapeutic alternative.We used the Najuta thoracic stent graft and successfully handled the pathology in a multiple-phase treatment.Technology is evolving with specific grafts for the ascending and fenestrated grafts for the aortic arch. In this single case the Najuta endograft, in spite of the periprocedural problems, was a valid therapeutic option.

show abstract

Carotid-axillary artery bypass: A ten-year experience

Abstract: This retrospective review demonstrates that a carotid-axillary bypass constructed with ringed synthetic graft material tunneled under the clavicle performs well and can be considered a reasonable alternative to the more standard carotid-subclavian bypass for the same indications.

Cited by 30 publications

References 11 publications

Technical Solutions for Common Problems in TEVAR:

Technical Solutions for Common Problems in TEVAR:

A Case Report of Coronary-Subclavian Steal Syndrome Treated with Carotid to Axillary Artery Bypass

Case Report of an Endovascular Repair of a Residual Type A Dissection Using a Not CE Not FDA-Approved Najuta Thoracic Stent Graft System

Contact Info

Product

Resources

About